MIM
CALC icon

Monashee Investment Management’s CalciMedica CALC Stock Holding History

Monashee Investment Management’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,000
Closed -$890K – 288
2020
Q3 		$890K Buy
+5,000
New +$1.04M 0.19% 101

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Monashee Investment Management's CALC Position: Q4 2020 in Review

Monashee Investment Management sold out of CalciMedica (CALC) in Q4 2020, closing a stake of 5,000 shares — an estimated $890K sold.

Monashee Investment Management first reported a position in CALC in Q3 2020 and held it in 1 quarter. The position peaked at $890K in Q3 2020. 33 funds tracked by Wall St. Rank hold CALC as of Q4 2020.

  • Monashee Investment Management reported no remaining CalciMedica position as of Q4 2020 after selling out during the quarter.
  • Monashee Investment Management sold 5,000 CalciMedica shares in Q4 2020, an estimated $890K.
  • Monashee Investment Management first reported a position in CalciMedica in Q3 2020 and held it in 1 quarter.
  • Monashee Investment Management's CalciMedica position peaked at $890K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held CalciMedica as of Q4 2020.

Based on Monashee Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.